Climb Bio, Inc. — Director's Dealing 2025

Jan 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Climb Bio, Inc. (CLYM)
CIK: 0001768446
Period of Report: 2025-01-01

Reporting Person: Thomas Stephen Basil (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-01	Common Stock	M	50188	—	Acquired	154095	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-01	Restricted Stock Units	$	M	50188	Disposed		Common Stock (50188)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: The RSUs were granted on June 27, 2024 and will vest as to 50% of the shares on January 1, 2025, as to 25% of the shares on March 27, 2025 and as to the remaining 25% of the shares on June 27, 2025, subject to the Reporting Person's continued service.